CTDH Stock, Ctd Holdings Inc Information

CTD Holdings, Inc. is a clinical stage biotechnology company that develops cyclodextrin based products for the treatment of diseases with unmet need. The company s Trappsol R Cyclo TM , an orphan drug designated product in the United States and the EU, is used to treat Niemann Pick Type C, a rare and fatal genetic disease. Additional indications for the active ingredient in Trappsol R Cyclo TM are in development. For additional information, visit the company s website: www.ctd holdings.com